Find clinical trials for Non-Small-Cell Lung Cancer in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near New York, NY, USA:
body radiation (SBRT) is a more effective treatment for early-stage non-small cell lung cancer (NSCLC) t...
Phase 2
New York, New York, United States and 8 other locations
Study of MGY825 single agent in adult patients with advanced non-small cell lung cancer....
Phase 1
New York, New York, United States and 14 other locations
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...
Phase 2
New York, New York, United States and 83 other locations
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
New York, New York, United States and 59 other locations
3-DXd will be evaluated in participants with metastatic or unresectable NSCLC with EGFR activating mutation or squamous or non-squamous NSCL...
Phase 1
New York, New York, United States and 35 other locations
with zimberelimab, and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non- ...
Phase 2
Lake Success, New York, United States and 47 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Bronx, New York, United States and 209 other locations
works compared to pembrolizumab alone in patients with non-small cell lung cancer (NSCLC) with high leve...
Phase 3
Nyack, New York, United States of America and 6 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
New York, New York, United States and 123 other locations
with separate sub- studies. Sub-study 1 includes participants with non-small cell lung cancer (NSCLC) wi...
Phase 2
New York, New York, United States and 65 other locations
Clinical trials
Research sites
Resources
Legal